DaVita Inc.
Profit after direct costs
Core business profitability
Bottom line profitability
Top line growth rate
Flow of revenue through cost categories to net income
| Item | Trend | 2021 | 2022 | 2023 | 2024 | 2025 | YoY Change |
|---|---|---|---|---|---|---|---|
Total Revenue | 11.62B | 11.61B | 12.14B | 12.82B | 13.64B | 6.5% | |
| Cost of Revenue | (7.97B) | (8.21B) | (8.32B) | (8.60B) | (9.96B) | 15.8% | |
Gross Profit | 3.65B | 3.40B | 3.82B | 4.22B | 3.68B | -12.6% | |
| Operating Expenses | |||||||
| Research & Development | — | — | — | — | — | — | |
| Selling, General & Administrative | (1.20B) | (1.36B) | (1.47B) | (1.54B) | (1.67B) | 8.8% | |
| General & Administrative | (1.20B) | (1.36B) | (1.47B) | (1.54B) | (1.67B) | 8.8% | |
| Depreciation & Amortization | (680.62M) | (732.60M) | (745.44M) | (723.86M) | (715.35M) | -1.2% | |
Operating Income (EBIT) | 1.80B | 1.34B | 1.60B | 2.09B | 2.01B | -3.8% | |
| Non-Operating Items | |||||||
| Interest Income | — | — | — | — | — | — | |
| Interest Expense | (285.25M) | (357.02M) | (398.55M) | (470.47M) | (549.67M) | 16.8% | |
| Other Income/Expenses (Net) | -278.88M | -372.78M | -425.69M | -560.09M | -663.79M | 18.5% | |
Income Before Tax | 1.52B | 966.28M | 1.18B | 1.53B | 1.35B | -12.0% | |
| Income Tax Expense | (306.73M) | (198.09M) | (220.12M) | (279.66M) | (293.11M) | 4.8% | |
Net Income | 978.45M | 560.40M | 691.53M | 936.34M | 746.80M | -20.2% | |
| Per Share Metrics | |||||||
| Earnings Per Share (Basic) | $9 | $6 | $8 | $11 | $10 | -11.8% | |
| Weighted Avg Shares Outstanding | 105.23M | 92.99M | 90.79M | 84.99M | 86.10M | 1.3% | |
| Weighted Avg Shares Outstanding (Diluted) | 109.95M | 95.83M | 93.18M | 87.27M | 88.10M | 0.9% | |
EBITDA | 2.48B | 2.06B | 2.32B | 2.72B | 2.64B | -3.0% |
Explore DVA
DVA in the Healthcare
Large Cap